相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。How can biosimilars change the trajectory of breast cancer therapy?
Dario Trapani et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2020)
Heart Disease and Stroke Statistics-2019 Update A Report From the American Heart Association
Emelia J. Benjamin et al.
CIRCULATION (2019)
The arrival of biosimilar monoclonal antibodies in oncology: clinical studies for trastuzumab biosimilars
Liese Barbier et al.
BRITISH JOURNAL OF CANCER (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Cost effectiveness and affordability of trastuzumab in sub-Saharan Africa for early stage HER2-positive breast cancer
Noga Gershon et al.
COST EFFECTIVENESS AND RESOURCE ALLOCATION (2019)
Knowledge and use of biosimilars in oncology: a survey by the European Society for Medical Oncology
Rosa Giuliani et al.
ESMO OPEN (2019)
Cost-Effectiveness of Adjuvant Trastuzumab Therapy for Early Breast Cancer in Asia: A Systematic Review
Noor Razilah Abdul Rafar et al.
VALUE IN HEALTH REGIONAL ISSUES (2019)
The Global Need for a Trastuzumab Biosimilar for Patients With HER2-Positive Breast Cancer
Kimberly Blackwell et al.
CLINICAL BREAST CANCER (2018)
Pathology and laboratory medicine: the Cinderella of health systems
Sabine Kleinert et al.
LANCET (2018)
Pathology and laboratory medicine in low-income and middle-income countries 1: Access to pathology and laboratory medicine services: a crucial gap
Michael L. Wilson et al.
LANCET (2018)
Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries
Claudia Allemani et al.
LANCET (2018)
THE ECONOMIC IMPACT OF SWITCHING TO TRASTUZUMAB BIOSIMILAR FOR THE TREATMENT OF METASTATIC BREAST CANCER FROM A CHINESE PAYER PERSPECTIVE
S. Liu et al.
VALUE IN HEALTH (2018)
Budget Impact Analysis of Biosimilar Trastuzumab for the Treatment of Breast Cancer in Croatia
August Cesarec et al.
APPLIED HEALTH ECONOMICS AND HEALTH POLICY (2017)
ESMO International Consortium Study on the availability, out-of-pocket costs and accessibility of antineoplastic medicines in countries outside of Europe
N. I. Cherny et al.
ANNALS OF ONCOLOGY (2017)
Pilot Survey of Breast Cancer Management in Sub-Saharan Africa
Verna D. N. K. Vanderpuye et al.
JOURNAL OF GLOBAL ONCOLOGY (2017)
ESMO European Consortium Study on the availability, out-of-pocket costs and accessibility of antineoplastic medicines in Europe
N. Cherny et al.
ANNALS OF ONCOLOGY (2016)
Public health interventions to protect against falsified medicines: a systematic review of international, national and local policies
William L. Hamilton et al.
HEALTH POLICY AND PLANNING (2016)
Overcoming Barriers to the Market Access of Biosimilars in the European Union: The Case of Biosimilar Monoclonal Antibodies
Evelien Moorkens et al.
FRONTIERS IN PHARMACOLOGY (2016)
Breast Cancer in Morocco: A Literature Review
Meriem Slaoui et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
Barriers to the Use of Trastuzumab for HER2+ Breast Cancer and the Potential Impact of Biosimilars: A Physician Survey in the United States and Emerging Markets
Philip Lammers et al.
PHARMACEUTICALS (2014)
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
Yung-Jue Bang et al.
LANCET (2010)
HER2 expression in breast cancer primary tumours and corresponding metastases.: Original data and literature review
J Carlsson et al.
BRITISH JOURNAL OF CANCER (2004)
分享论文
